Allergology International

Plasma miR223 is a possible biomarker for diagnosing patients with severe atopic dermatitis

Publication date: Available online 1 September 2020Source: Allergology InternationalAuthor(s): Risa Yasuike, Risa Tamagawa-Mineoka, Naomi Nakamura, Koji Masuda, Norito Katoh

Allergology International

Wed Sep 02, 2020 17:44

Mark above section as read

 Allergy

Personalized Medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model

Abstract The introduction of personalized medicine (PM) has been a milestone in the history of medical therapy, because it has revolutionized the previous approach of treating the disease with that of treating the patient. It is known today that diseases can occur in different genetic variants, making specific treatments of proven efficacy necessary for a given endotype. Allergic diseases are particularly suitable for PM, because they meet the therapeutic success requirements, including a known...

Allergy

Tue Sep 01, 2020 13:17

Mark above section as read

 Allergy and Clinical Immunology

Enhancing the prediction of childhood asthma remission: integrating clinical factors with microRNAs

Publication date: Available online 2 September 2020Source: Journal of Allergy and Clinical ImmunologyAuthor(s): Alberta L. Wang, Jiang Li, Alvin T. Kho, Michael J. McGeachie, Kelan G. Tantisira

Allergy and Clinical Immunology

Wed Sep 02, 2020 21:19

Coagulation factors induce human skin mast cell- and basophil-degranulation via activation of complement 5 and the C5a receptor

Publication date: Available online 2 September 2020Source: Journal of Allergy and Clinical ImmunologyAuthor(s): Yuhki Yanase, Yoshimi Matsuo, Shunsuke Takahagi, Tomoko Kawaguchi, Kazue Uchida, Kaori Ishii, Akio Tanaka, Daiki Matsubara, Koichiro Ozawa, Michihiro Hide

Allergy and Clinical Immunology

Wed Sep 02, 2020 21:19

Efficacy and economics of targeted panel versus whole exome sequencing in 878 patients with suspected primary immunodeficiency

Publication date: Available online 2 September 2020Source: Journal of Allergy and Clinical ImmunologyAuthor(s): Craig D. Platt, Fatima Zaman, Wayne Bainter, Kelsey Stafstrom, Abuarahman Almutairi, Margot Reigle, Sabrina Weeks, Raif S. Geha, Janet Chou, International Consortium for Immunodeficiencies

Allergy and Clinical Immunology

Wed Sep 02, 2020 21:19

Mark above section as read

 Annals of Allergy, Asthma & Immunology

Eosinophilic fasciitis in common variable immunodeficiency with hypereosinophilia

Eosinophilic fasciitis or Shulman disease is a rare disorder that presents with scleroderma-like changes of connective tissues accompanied by elevated erythrocyte sedimentation rate, hypergammaglobulinemia, and transient peripheral eosinophilia.1 There have been two cases of common variable immunodeficiency (CVID) associated with eosinophilic fasciitis reported in Europe. We report the first case of CVID associated with eosinophilic fasciitis in the United States in the setting of hypereosinophilia.

Annals of Allergy, Asthma & Immunology

Wed Sep 02, 2020 03:00